EPM2A glucan phosphatase, laforin

Summary
Gene Symbol
  • EPM2A
Aliases
  • LD
  • LDE
Organism
Homo sapiens (human)
External Links
NCBI Gene
7957
HGNC
3413
PubChem
7957
Alliance of Genome Resources
Annotation
Keyword
  • 3D-structure
  • Alternative initiation
  • Alternative splicing
  • Autophagy
  • Cell membrane
  • Cytoplasm
  • Disease variant
  • Endoplasmic reticulum
  • Epilepsy
  • Glycogen metabolism
  • Glycogen storage disease
  • Neurodegeneration
  • Nucleus
  • Phosphoprotein
  • Protein phosphatase
  • Reference proteome
  • Ubl conjugation
Proteins
Displaying 1 entry
UniProt Protein Name
O95278
  • Glucan phosphatase
  • Glycogen phosphatase
  • Lafora PTPase
Gene Ontology (GO)
GO Hierarchy
Disease
Disease Ontology
Displaying entries 61 - 70 of 77 in total
DO ID Disease Name Source
DOID:3534 Lafora disease
DOID:3535 Unverricht-Lundborg syndrome
DOID:4090 agnosia
DOID:4428 dyslexia
DOID:4766 embryoma
DOID:4964 neurotic disorder
DOID:529 blepharospasm
DOID:5418 schizoaffective disorder
DOID:5419 schizophrenia
DOID:5823 childhood lymphoma
The Human Phenotype Ontology
Displaying entries 1 - 10 of 39 in total
HPO ID HPO Term
HP:0000007 Autosomal recessive inheritance
HP:0000572 Visual loss
HP:0000709 Psychosis
HP:0000712 Emotional lability
HP:0000716 Depression
HP:0000726 Dementia
HP:0000992 Cutaneous photosensitivity
HP:0001250 Seizure
HP:0001251 Ataxia
HP:0001257 Spasticity
Displaying all 2 entries
Disease ID Disease Name
ORPHA:501
  • Lafora disease
OMIM:254780
  • myoclonic epilepsy of Lafora 1

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024